GH1 and chronic kidney disease: GH therapy induced a trend toward increased α-Klotho concentrations both in the CKD group (554 (388–659) to 591 (358–742) pg/mL (P = 0.19)) and the healthy controls (547 (421–711) pg/mL to 654 (538–754) pg/mL (P = 0.13)).